CClinicalTrials.gg
CompletedNCT02701777Updated Jul 21, 2022Results posted

Enhancing STDP After Spinal Cord Injury

An interventional study of STDP and Training in Spinal Cord Injury, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-21.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The overall goal is to develop new clinical approaches to restore limb function after spinal cord injury (SCI). Corticospinal tract (CST) axons are involved in controlling limb function. Paired pulse induced spike-timing dependent plasticity (STDP) enhances synaptic strength between residual CST axons and spinal motoneurons (SMNs) resulting in temporary improvements in limb function in humans with incomplete SCI. Motor training will be combined with paired-pulse STDP stimulation to further enhance plasticity and behavioral recovery.

Read the detailed description

To induce STDP with paired pulse, corticospinal volleys evoked by either transcranial magnetic stimulation over the primary motor cortex for upper extremities or electrical stimulation over the thoracic spine for lower extremities arrive at corticospinal-motor neuronal synapses of upper- or lower-limb muscles, 1-2 ms before antidromic potentials were elicited in motor neurons by electrical stimulation of corresponding peripheral nerves.

02

Conditions studied

  • Spinal Cord Injury

Keywords

  • spike timing dependant plasticity
03

In context

Spinal Cord Injuries

1,950 studies on the registry are indexed under Spinal Cord Injuries; 507 are open to participants now.

This study's enrollment of 62 is above the median of 24 across 1,567 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Participants who are unimpaired healthy controls:

  • Male and females between ages 18-85 years
  • Right handed
  • Able to complete precision grips with both hands
  • Able to complete full wrist flexion-extension bilaterally
  • Able to walk unassisted
  • Able to complete full ankle flexion-extension bilaterally

Participants who have had a spinal cord injury:

  • Male and females between ages 18-85 years
  • SCI ( 6 months of injury)
  • Spinal Cord injury at or above L5
  • The ability to produce a visible precision grip force with one hand
  • Able to perform some small wrist flexion and extension
  • The ability to perform a small visible contraction with dorsiflexion and hip flexor muscles
  • No subjects will be excluded based on their race, religion, ethnicity, gender or HIV status.
  • ASIA A,B,C, or D

Exclusion criteria

Exclusion Criteria:

Exclusion criteria for enrollment For SCI and Healthy Control Subjects (4-8 exclusion for non-invasive brain stimulation only):

  • Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease
  • Any debilitating disease prior to the SCI that caused exercise intolerance
  • Premorbid, ongoing major depression or psychosis, altered cognitive status
  • History of head injury or stroke
  • Metal plate in skull
  • History of seizures
  • Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold (see appendix 2)
  • Pregnant females
  • Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal cord disease such as spinal stenosis, spina bifida, MS, or herniated disk
  • Individuals with scalp shrapnel, cochlear implants, or aneurysm clips.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
62 participants (actual)

Study arms

  • Active comparator
    STDP

    Paired stimulation will be given to the brain and to a peripheral nerve so that the messages are received at the spinal cord at predetermined time.

    Other: STDP

  • Active comparator
    STDP + Training

    Paired stimulation will be given to the brain and to a peripheral nerve so that the messages are received at the spinal cord at predetermined time. Motor training will follow paired stimulation.

    Other: STDP · Behavioral: Training

  • Active comparator
    Sham STDP + Training

    Sham or fake paired stimulation will be given to the brain and to a peripheral nerve so that the messages are received at the spinal cord at predetermined times. Motor training will follow stimulation.

    Behavioral: Training · Other: Sham STDP

  • Other
    Multisite-STDP + Training

    Prospective Single Cohort Multisite-Paired stimulation will be given to the brain and to a peripheral nerve so that the messages are received at the spinal cord at predetermined time. Motor training will follow paired stimulation.

    Behavioral: Training · Other: Multisite-STDP

Interventions

  • OtherSTDP

    Paired stimulation will be given to the brain and to a peripheral nerve so that the messages are received at the spinal cord at predetermined time.

    Also known as: Paired stimulation

  • BehavioralTraining

    The participant will be asked to perform exercises using their hands and arms.

  • OtherSham STDP

    Sham or fake paired stimulation will be given to the brain and to a peripheral nerve so that the messages are received at the spinal cord at predetermined times.

  • OtherMultisite-STDP

    Paired stimulation will be given to the brain bilaterally, thoracic spine, and several peripheral nerve so that the messages are received at the spinal cord at predetermined time.

06

What researchers measure

Primary outcomes

  1. Functional Assessment

    The Graded Redefined Assessment of Strength Sensibility and Prehension (GRASSP) assessment is a standardized test of functional abilities of the hand. We measure time required to complete the GRASSP test for upper extremity functional assessment. 10-m walk test is used to measure walking speed for lower extremity functional assessment. The time to complete the task is assessed in seconds for both measurements and normalized as percentage of Baseline. Normalization to baseline allows comparison across two different tasks. For STDP, STDP+Training, and Sham-STDP+Training groups, either GRASSP or 10-m walk test was performed in each participant depending on the targeted muscle. For Multisite-STDP + Training group, both GRASSP and 10-m walk test were performed in each participant and the average of two tests were reported below.

    Time frame: Measured at baseline, after 10-20 sessions, and follow up (after 6 months) for STDP, STDP+Training, and Sham-STDP+Training groups . Measured at baseline, after 20 and 40 sessions, and follow up (after 9 months) for Multisite-STDP + Training group.

Secondary outcomes

  1. Amplitude of Motor Evoked Potential (MEP)

    We measure amplitude of a motor evoked potential evoked by transcranial magnetic stimulation (TMS) or thoracic spine stimulation. The amplitude of MEP is assessed in millivolts and normalized as percentage of Baseline. Normalization to baseline is necessary to allow comparison across different muscles because the targeted muscle is different for each individual depending on the level of injury.

    Time frame: Measured at baseline, after 10-20 sessions, and follow up (after 6 months) for STDP, STDP+Training, and Sham-STDP+Training groups . Measured at baseline and after 20 and 40 sessions for Multisite-STDP + Training group.

  2. Maximum Voluntary Contraction

    We measure maximum voluntary contraction (MVC) of muscles recorded by electromyography (EMG) in the targeted muscle(s). Average of muscles was reported for Multisite-STDP + Training group. The maximum voluntary contraction is assessed in millivolts and normalized as percentage of Baseline. Normalization to baseline is needed to allow comparison across different muscles because the targeted muscle is different for each individual depending on the level of injury.

    Time frame: Measured at baseline, after 10-20 sessions, and follow up (after 6 months) for STDP, STDP+Training, and Sham-STDP+Training groups . Measured at baseline and after 20 and 40 sessions for Multisite-STDP + Training group.

  3. ISNCSCI-motor Scores

    Neurological recovery was measured by the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Motor part of the exam is completed through the testing of key muscle functions corresponding to 10 myotomes (C5-T1 and L2-S1) for right and left side separately. The strength of each muscle function is graded on a six-point scale ranging from 0 meaning complete paralysis to 5 meaning full strength. The total motor score is sum of all motor scores across 10 myotomes for both sides and therefore ranges from 0-100. Higher scores represent better outcome. We reported the total motor score.

    Time frame: ISNCSCI was performed at baseline and after 40 sessions of Multisite-STDP+Training.

  4. ISNCSCI-sensory Scores

    Neurological recovery was measured by the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Sensory part of the exam is completed through the testing of a key point in each of the 28 dermatomes (from C2 to S4-5) on the right and left sides of the body. At each of these key points, two aspects of sensation are examined: light touch and pin prick (sharp-dull discrimination). Appreciation of light touch and pin prick sensation at each of the key points is separately scored on a three-point scale; 0-absent, 1-altered, and 2-normal or intact. Therefore, 56 is the maximum score for both light touch and pin prick and the total sensory score ranges from 0 to 112. Higher scores represent better outcome. We reported the total sensory score.

    Time frame: ISNCSCI was performed at baseline and after 40 sessions of Multisite-STDP+Training.

  5. SCI-QOL-ambulation

    We used questionnaire to assess changes in quality of life. The name of the questionnaire is Spinal Cord Injury Quality of Life (SCI-QOL) and we used four subdomains: ambulation, self-care, bowel management difficulties, and bladder management difficulties. Scores on all subdomains of SCI-QOL use a standardized T metric, with a mean of 50 and a standard deviation of 10. Ambulation subdomain assesses the ability to engage in walking activities in different locations that vary based on speed, time and condition and the ability to manage stairs under different conditions. Higher scores on Ambulation subdomain represent better outcome.

    Time frame: Measured at baseline, after 40 sessions, and follow up (after 9 months) for Multisite-STDP + Training group.

  6. SCI-QOL-self-care

    We used questionnaire to assess changes in quality of life. The name of the questionnaire is Spinal Cord Injury Quality of Life (SCI-QOL) and we used four subdomains: ambulation, self-care, bowel management difficulties, and bladder management difficulties. Scores on all subdomains of SCI-QOL use a standardized T metric, with a mean of 50 and a standard deviation of 10. Self-care subdomain assesses an individual's ability to perform daily self-care activities such as eating, dressing, grooming, and bathing. Higher scores on Self-care subdomain represent better outcome.

    Time frame: Measured at baseline, after 40 sessions, and follow up (after 9 months) for Multisite-STDP + Training group.

  7. SCI-QOL- Bowel Management Difficulties

    We used questionnaire to assess changes in quality of life. The name of the questionnaire is Spinal Cord Injury Quality of Life (SCI-QOL) and we used four subdomains: ambulation, self-care, bowel management difficulties, and bladder management difficulties. Scores on all subdomains of SCI-QOL use a standardized T metric, with a mean of 50 and a standard deviation of 10. Bowel management difficulties subdomain measures a range of difficulties associated with bowel management, including an ability to carry out a bowel program; concerns about incontinence and bowel accidents; concerns about difficulty implementing a bowel program; and the impact of bowel management on everyday living. Higher scores on bowel management difficulties subdomain represent better outcome.

    Time frame: Measured at baseline, after 40 sessions, and follow up (after 9 months) for Multisite-STDP + Training group.

  8. SCI-QOL- Bladder Management Difficulties

    We used questionnaire to assess changes in quality of life. The name of the questionnaire is Spinal Cord Injury Quality of Life (SCI-QOL) and we used four subdomains: ambulation, self-care, bowel management difficulties, and bladder management difficulties. Scores on all subdomains of SCI-QOL use a standardized T metric, with a mean of 50 and a standard deviation of 10. Bladder management difficulties subdomain measures a range of difficulties associated with bladder management, including ability to carry out a bladder program; worry about bladder accidents; concerns about implementing one's bladder program; and impact on everyday living. Higher scores on bladder management difficulties subdomain represent better outcome.

    Time frame: Measured at baseline, after 40 sessions, and follow up (after 9 months) for Multisite-STDP + Training group.

07

Results

Posted Jan 20, 2021

Participant flow

Participant flow — Overall Study
MilestoneSTDPSTDP + TrainingSham STDP + TrainingMultisite-STDP + Training
Started17161613
Completed13131211
Not completed4342
Withdrew: Some subjects did not like the stimulation.4002
Withdrew: Some subjects were unable to commit to the training study.0340

Outcome measures

PrimaryFunctional Assessment

The Graded Redefined Assessment of Strength Sensibility and Prehension (GRASSP) assessment is a standardized test of functional abilities of the hand. We measure time required to complete the GRASSP test for upper extremity functional assessment. 10-m walk test is used to measure walking speed for lower extremity functional assessment. The time to complete the task is assessed in seconds for both measurements and normalized as percentage of Baseline. Normalization to baseline allows comparison across two different tasks. For STDP, STDP+Training, and Sham-STDP+Training groups, either GRASSP or 10-m walk test was performed in each participant depending on the targeted muscle. For Multisite-STDP + Training group, both GRASSP and 10-m walk test were performed in each participant and the average of two tests were reported below.

Time frame:
Measured at baseline, after 10-20 sessions, and follow up (after 6 months) for STDP, STDP+Training, and Sham-STDP+Training groups . Measured at baseline, after 20 and 40 sessions, and follow up (after 9 months) for Multisite-STDP + Training group.
Reported as:
Mean · percentage of Baseline
Functional Assessment
percentage of BaselineSTDPSTDP + TrainingSham STDP + TrainingMultisite-STDP + Training
Baseline100 ± 0100 ± 0100 ± 0100 ± 0
After 10 sessions80.5 ± 9.175.6 ± 18.682.6 ± 20.1—
After 20 sessions———62.4 ± 10.9
After 40 sessions———49.1 ± 10.9
Follow-up—78.4 ± 9.6100.6 ± 10.548.3 ± 16.5
SecondaryAmplitude of Motor Evoked Potential (MEP)

We measure amplitude of a motor evoked potential evoked by transcranial magnetic stimulation (TMS) or thoracic spine stimulation. The amplitude of MEP is assessed in millivolts and normalized as percentage of Baseline. Normalization to baseline is necessary to allow comparison across different muscles because the targeted muscle is different for each individual depending on the level of injury.

Time frame:
Measured at baseline, after 10-20 sessions, and follow up (after 6 months) for STDP, STDP+Training, and Sham-STDP+Training groups . Measured at baseline and after 20 and 40 sessions for Multisite-STDP + Training group.
Reported as:
Mean · percentage of Baseline
Amplitude of Motor Evoked Potential (MEP)
percentage of BaselineSTDPSTDP + TrainingSham STDP + TrainingMultisite-STDP + Training
Baseline100 ± 0100 ± 0100 ± 0100 ± 0
After 10 sessions153.2 ± 40.7164.6 ± 64.099.1 ± 12.4—
After 20 sessions———233.2 ± 65.9
After 40 sessions———368.9 ± 108.9
Follow-up—172 ± 57.789.0 ± 22.1—
SecondaryMaximum Voluntary Contraction

We measure maximum voluntary contraction (MVC) of muscles recorded by electromyography (EMG) in the targeted muscle(s). Average of muscles was reported for Multisite-STDP + Training group. The maximum voluntary contraction is assessed in millivolts and normalized as percentage of Baseline. Normalization to baseline is needed to allow comparison across different muscles because the targeted muscle is different for each individual depending on the level of injury.

Time frame:
Measured at baseline, after 10-20 sessions, and follow up (after 6 months) for STDP, STDP+Training, and Sham-STDP+Training groups . Measured at baseline and after 20 and 40 sessions for Multisite-STDP + Training group.
Reported as:
Mean · percentage of Baseline
Maximum Voluntary Contraction
percentage of BaselineSTDPSTDP + TrainingSham STDP + TrainingMultisite-STDP + Training
Baseline100 ± 0100 ± 0100 ± 0100 ± 0
After 10 sessions139.4 ± 23.3144.6 ± 50.7100.7 ± 12.3—
After 20 sessions———161.0 ± 49.5
After 40 sessions———193.1 ± 71.0
follow-up—154.5 ± 25.0108.8 ± 7.8—
SecondaryISNCSCI-motor Scores

Neurological recovery was measured by the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Motor part of the exam is completed through the testing of key muscle functions corresponding to 10 myotomes (C5-T1 and L2-S1) for right and left side separately. The strength of each muscle function is graded on a six-point scale ranging from 0 meaning complete paralysis to 5 meaning full strength. The total motor score is sum of all motor scores across 10 myotomes for both sides and therefore ranges from 0-100. Higher scores represent better outcome. We reported the total motor score.

Time frame:
ISNCSCI was performed at baseline and after 40 sessions of Multisite-STDP+Training.
Reported as:
Mean · scores on a scale
ISNCSCI-motor Scores
scores on a scaleMultisite-STDP + Training
Baseline59.4 ± 23.7
After 40 sessions68.9 ± 20.2
SecondaryISNCSCI-sensory Scores

Neurological recovery was measured by the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Sensory part of the exam is completed through the testing of a key point in each of the 28 dermatomes (from C2 to S4-5) on the right and left sides of the body. At each of these key points, two aspects of sensation are examined: light touch and pin prick (sharp-dull discrimination). Appreciation of light touch and pin prick sensation at each of the key points is separately scored on a three-point scale; 0-absent, 1-altered, and 2-normal or intact. Therefore, 56 is the maximum score for both light touch and pin prick and the total sensory score ranges from 0 to 112. Higher scores represent better outcome. We reported the total sensory score.

Time frame:
ISNCSCI was performed at baseline and after 40 sessions of Multisite-STDP+Training.
Reported as:
Mean · scores on a scale
ISNCSCI-sensory Scores
scores on a scaleMultisite-STDP + Training
Baseline99.0 ± 34.6
After 40 sessions119.9 ± 38.4
SecondarySCI-QOL-ambulation

We used questionnaire to assess changes in quality of life. The name of the questionnaire is Spinal Cord Injury Quality of Life (SCI-QOL) and we used four subdomains: ambulation, self-care, bowel management difficulties, and bladder management difficulties. Scores on all subdomains of SCI-QOL use a standardized T metric, with a mean of 50 and a standard deviation of 10. Ambulation subdomain assesses the ability to engage in walking activities in different locations that vary based on speed, time and condition and the ability to manage stairs under different conditions. Higher scores on Ambulation subdomain represent better outcome.

Time frame:
Measured at baseline, after 40 sessions, and follow up (after 9 months) for Multisite-STDP + Training group.
Reported as:
Mean · T-scores
SCI-QOL-ambulation
T-scoresMultisite-STDP + Training
Baseline53.7 ± 9.4
After 40 sessions57.1 ± 7.9
Follow-up61.4 ± 5.3
SecondarySCI-QOL-self-care

We used questionnaire to assess changes in quality of life. The name of the questionnaire is Spinal Cord Injury Quality of Life (SCI-QOL) and we used four subdomains: ambulation, self-care, bowel management difficulties, and bladder management difficulties. Scores on all subdomains of SCI-QOL use a standardized T metric, with a mean of 50 and a standard deviation of 10. Self-care subdomain assesses an individual's ability to perform daily self-care activities such as eating, dressing, grooming, and bathing. Higher scores on Self-care subdomain represent better outcome.

Time frame:
Measured at baseline, after 40 sessions, and follow up (after 9 months) for Multisite-STDP + Training group.
Reported as:
Mean · T-scores
SCI-QOL-self-care
T-scoresMultisite-STDP + Training
Baseline45.9 ± 7.8
After 40 sessions47.5 ± 8.0
Follow-up48.5 ± 3.6
SecondarySCI-QOL- Bowel Management Difficulties

We used questionnaire to assess changes in quality of life. The name of the questionnaire is Spinal Cord Injury Quality of Life (SCI-QOL) and we used four subdomains: ambulation, self-care, bowel management difficulties, and bladder management difficulties. Scores on all subdomains of SCI-QOL use a standardized T metric, with a mean of 50 and a standard deviation of 10. Bowel management difficulties subdomain measures a range of difficulties associated with bowel management, including an ability to carry out a bowel program; concerns about incontinence and bowel accidents; concerns about difficulty implementing a bowel program; and the impact of bowel management on everyday living. Higher scores on bowel management difficulties subdomain represent better outcome.

Time frame:
Measured at baseline, after 40 sessions, and follow up (after 9 months) for Multisite-STDP + Training group.
Reported as:
Mean · T-scores
SCI-QOL- Bowel Management Difficulties
T-scoresMultisite-STDP + Training
Baseline48.2 ± 10.6
After 40 sessions51.8 ± 10.7
Follow-up45.4 ± 7.3
SecondarySCI-QOL- Bladder Management Difficulties

We used questionnaire to assess changes in quality of life. The name of the questionnaire is Spinal Cord Injury Quality of Life (SCI-QOL) and we used four subdomains: ambulation, self-care, bowel management difficulties, and bladder management difficulties. Scores on all subdomains of SCI-QOL use a standardized T metric, with a mean of 50 and a standard deviation of 10. Bladder management difficulties subdomain measures a range of difficulties associated with bladder management, including ability to carry out a bladder program; worry about bladder accidents; concerns about implementing one's bladder program; and impact on everyday living. Higher scores on bladder management difficulties subdomain represent better outcome.

Time frame:
Measured at baseline, after 40 sessions, and follow up (after 9 months) for Multisite-STDP + Training group.
Reported as:
Mean · T-scores
SCI-QOL- Bladder Management Difficulties
T-scoresMultisite-STDP + Training
Baseline41.0 ± 9.5
After 40 sessions46.7 ± 7.6
Follow-up40.9 ± 7.6

Adverse events

Collected over The adverse event data is collected from baseline to completion of study visits, an average of 2~3 weeks for Arms 1-3. The longer experiment, Arm 4, involves ~50 visits (40 sessions + baseline, post 20, post 40, and follow-up assessments). This gives a total of 10~15 weeks.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
STDP0/17 (0%)0/17 (0%)0/17 (0%)
STDP + Training0/16 (0%)0/16 (0%)0/16 (0%)
Sham STDP + Training0/16 (0%)0/16 (0%)0/16 (0%)
Multisite-STDP + Training0/13 (0%)0/13 (0%)0/13 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)STDPSTDP + TrainingSham STDP + TrainingMultisite-STDP + TrainingTotal
<=18 years00000
Between 18 and 65 years121112843
>=65 years12036
Age, Continuous
Age, Continuous(years)STDPSTDP + TrainingSham STDP + TrainingMultisite-STDP + TrainingTotal
Mean45.1 (21 to 71)45.6 (23 to 82)41.8 (22 to 59)48.2 (21 to 84)45 (21 to 84)
Sex: Female, Male
Sex: Female, Male(Participants)STDPSTDP + TrainingSham STDP + TrainingMultisite-STDP + TrainingTotal
Female441514
Male9911635
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)STDPSTDP + TrainingSham STDP + TrainingMultisite-STDP + TrainingTotal
Hispanic or Latino686222
Not Hispanic or Latino756927
Unknown or Not Reported00000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)STDPSTDP + TrainingSham STDP + TrainingMultisite-STDP + TrainingTotal
American Indian or Alaska Native00000
Asian00000
Native Hawaiian or Other Pacific Islander03306
Black or African American305210
White550818
More than one race554115
Unknown or Not Reported00000
Region of Enrollment
Region of Enrollment(Participants)STDPSTDP + TrainingSham STDP + TrainingMultisite-STDP + TrainingTotal
United States1313121149
Time post injury
Time post injury(years)STDPSTDP + TrainingSham STDP + TrainingMultisite-STDP + TrainingTotal
Mean7.1 ± 5.412.7 ± 12.59.1 ± 6.18.9 ± 10.69.5 ± 9.1
08

Study locations

1 site
  • Edward Hines Jr. VA Hospital, Hines, IL
    Hines, Illinois 60141-5000, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Aug 5, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02701777
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Mar 8, 2016
Start date
Mar 1, 2016
Primary completion
Oct 30, 2020
Completion
Oct 30, 2020
Results posted
Jan 20, 2021
Last update
Jul 21, 2022

Study contacts

Martin Oudega, PhD
principal investigator · Edward Hines Jr. VA Hospital, Hines, IL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion